Stepan Co: Form 10-Q for the period ended Jun 30, 2014
Filed with the SEC on Jul 30, 2014 and accepted by EDGAR at Jul 30, 2014, 10:27 ET.
Management's discussion and analysis
As filed, 61,210 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim period included in the accompanying condensed consolidated financial statements.
The matters discussed in the MD&A include forward-looking statements that are subject to certain risks, uncertainties and assumptions. Such forward-looking statements are intended to be identified in this document by the words, “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. Actual results may vary materially.
Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them to reflect changes that occur after that date. Factors that could cause actual results to differ materially include the items described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.
Overview
The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:
- Surfactants – Surfactants, which accounted for 68 percent of consolidated net sales in the first half of 2014, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications include fabric softeners, germicidal quaternary compounds, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications such as latex systems, plastics and composites. Surfactants are manufactured at six North American sites (five in the U.S. and one in Canada), three European sites (United Kingdom, France and Germany), three Latin American sites (Mexico, Brazil and Colombia) and two Asian sites (Philippines and Singapore). The Company also holds a 50 percent ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields (enhanced oil recovery or EOR). The joint venture is accounted for under the equity method, and its financial results are excluded from the Surfactants segment operating results. Sales and related profits of the Company’s surfactants to enhanced oil recovery customers are included in Surfactants segment results.
- Polymers – Polymers, which accounted for 27 percent of consolidated net sales in the first half of 2014, include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers (collectively CASE products) and flexible foams. Polyester resins, which include liquid and powdered resins, are used in CASE and polyurethane systems house applications. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, the Company uses
phthalic anhydride internally in the production of polyols. In the U.S., polyurethane polyols and phthalic anhydride are manufactured at the Company’s Millsdale, Illinois, site and polyester resins are manufactured at the Company’s Columbus, Georgia, site. In Europe, polyols are manufactured at the Company’s subsidiaries in Germany and Poland. In Asia, polyols are currently toll produced for the Company’s 80-percent owned joint venture in Nanjing, China.
- Specialty Products – Specialty Products, which accounted for 5 percent of consolidated net sales in the first half of 2014, include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications. Specialty Products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors.
Deferred Compensation Plans
The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed in the following table:
(In millions)
| Income (Expense) For the Three Months Ended June 30 2014 | 2013 | Change | ||
|---|---|---|---|---|
| Deferred Compensation (Administrative expense) | $5.5 | $3.6 | $1.9 | (1) |
| Realized/Unrealized Gains on Investments (Other, net) | 0.5 | 0.2 | 0.3 | |
| Investment Income (Other, net) | — | — | — | |
| Pretax Income Effect | $6.0 | $3.8 | $2.2 |
(In millions)
| Income (Expense) For the Six Months Ended June 30 2014 | 2013 | Change | |
|---|---|---|---|
| Deferred Compensation (Administrative expense) | $5.7 | $(1.3) | $7.0 (1) |
| Realized/Unrealized Gains on Investments (Other, net) | 0.5 | 1.0 | (0.5) |
| Investment Income (Other, net) | 0.2 | 0.1 | 0.1 |
| Pretax Income Effect | $6.4 | $(0.2) | $6.6 |
(1) See the Corporate Expenses section of this management’s discussion and analysis for details regarding the quarter-over-quarter and year-over-year changes in deferred compensation expense.
Effects of Foreign Currency Translation
The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following table presents the effects that foreign currency translation had on the quarter-over-quarter changes in consolidated net sales and various income line items for the three and six month periods ended June 30, 2014 and 2013:
(In millions)
| Three Months Ended June 30 2014 | 2013 | Increase (Decrease) | Increase Due to Foreign Translation | |
|---|---|---|---|---|
| Net Sales | $504.1 | $474.4 | $29.7 | $3.2 |
| Gross Profit | 71.6 | 73.7 | (2.1) | 0.3 |
| Operating Income | 36.9 | 35.9 | 1.0 | 0.1 |
| Pretax Income | 33.2 | 32.2 | 1.0 | 0.2 |
(In millions)
| Six Months Ended June 30 2014 | 2013 | Increase (Decrease) | Increase (Decrease) Due to Foreign Translation | |
|---|---|---|---|---|
| Net Sales | $981.6 | $931.0 | $50.6 | $1.5 |
| Gross Profit | 134.6 | 146.4 | (11.8) | (0.1) |
| Operating Income | 59.4 | 64.2 | (4.8) | (0.2) |
| Pretax Income | 51.3 | 57.5 | (6.2) | 0.1 |
28
RESULTS OF OPERATIONS
Three Months Ended June 30, 2014 and 2013
Summary
Net income attributable to the Company for the second quarter of 2014 increased seven percent quarter-over-quarter to $24.4 million, or $1.06 per diluted share, compared to $22.7 million, or $0.99 per diluted share, for the second quarter of 2013. Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the second quarter of 2014 follows the summary.
Consolidated net sales increased $29.7 million, or six percent, quarter over quarter. Higher average selling prices and the effects of foreign currency translation favorably affected the net sales change by $35.6 million and $3.2 million, respectively. A two percent decline in sales volume negatively affected the change in net sales by $9.1 million. The increase in average selling prices was primarily attributable to higher quarter-over-quarter raw material costs for Surfactants. The Surfactants segment accounted for the consolidated sales volume decrease. Surfactants sales volume declined eight percent largely due to reduced quarter-over-quarter volumes for North American operations. Sales volume for the Polymers segment increased 22 percent due to strong growth in North America and Europe as well to the contribution of the North American polyester resins business acquired from BMS in June 2013. Sales volume for Specialty Products was up less than one percent.
Operating income for the second quarter of 2014 increased $1.0 million, or three percent, over operating income reported for the same quarter of 2013. Gross profit declined $2.1 million, or three percent, mainly due to lower profits for Surfactants caused by lower sales volume and higher expenses for North American operations. The gross profit decrease for Surfactants was partially offset by a 26 percent quarter-over-quarter increase in gross profit for Polymers, primarily driven by the sales volume growth.
Operating expenses declined $3.2 million, or eight percent, between quarters. Deferred compensation accounted for $1.9 million of the decrease. The following summarizes the quarter-over-quarter changes in the individual income statement line items that comprise the Company’s operating expenses:
- Administrative expenses declined $2.5 million, or 21 percent, quarter over quarter largely due to a $1.9 million increase in deferred compensation income. A decline in the value of Company common stock that was larger in the second quarter of 2014 than the decline occurring in the second quarter 2013 led to the quarter-over-quarter decline. See the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details. Decreases in fringe benefit, patent maintenance and insurance expenses contributed to the lower administrative expenses.
- Selling expenses declined $0.9 million, or seven percent, quarter over quarter. The decrease reflected lower fringe benefit and consulting expenses.
- Research, development and technical service expenses (R&D) were up $0.2 million, or two percent, quarter over quarter.
Net interest expense for the second quarter of 2014 increased $0.7 million, or 30 percent, over net interest expense for the second quarter of last year. The increase reflected higher quarter-over-quarter average debt levels arising from the $100.0 million private placement note purchase agreement the Company executed in June 2013. The Company borrowed the funds to finance the second quarter 2013 Bayer MaterialScience (BMS) North American polyester resins acquisition, other capital expenditures and general corporate purposes.
Other, net was $0.6 million of income for the second quarter of 2014 compared to less than $0.1 million of expense for the second quarter of 2013. Investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets increased $0.5 million between quarters to $0.7 million in the second quarter of 2014 compared from $0.2 million in last year’s second quarter. Foreign exchange losses totaled $0.1 million for the second quarter of 2014 compared to $0.2 million for the same quarter a year ago.
The effective tax rate was 26.6 percent for the second quarter of 2014 compared to 29.6 percent for the second quarter of 2013. The decrease was primarily attributable to a greater percentage of consolidated income being generated outside the U.S. where the effective tax rates are generally lower. This decrease was partially offset by the expiration of the U.S. research and development tax credit and the small agri-biodiesel producer tax credit.
Segment Results
(In thousands)
| For the three months ended June 30, 2014 | Surfactants | Polymers | Specialty Products | Segment Results | Corporate | Total |
|---|---|---|---|---|---|---|
| Net sales | $333,761 | $148,270 | $22,080 | $504,111 | — | $504,111 |
| Operating income | 19,239 | 18,444 | 3,550 | 41,233 | (4,319) | 36,914 |
| For the three months ended June 30, 2013 | ||||||
| Net sales | $331,087 | $121,325 | $22,033 | $474,445 | — | $474,445 |
| Operating income | 25,966 | 13,524 | 4,197 | 43,687 | (7,818) | 35,869 |
Surfactants
Surfactants net sales for the second quarter of 2014 increased $2.7 million, or one percent, over net sales for the second quarter of 2013. Higher average selling prices, due largely to higher raw material costs, and the effects of foreign currency translation accounted for $27.5 million and $0.6 million, respectively, of the net sales improvement. An eight percent decline in sales volume negatively affected the net sales change by $25.4 million. All regions except Asia reported lower sales volumes between quarters. A quarter-over-quarter comparison of net sales by region follows:
(In thousands)
| For the Three Months Ended June 30, 2014 | June 30, 2013 | Increase (Decrease) | Percent Change | |
|---|---|---|---|---|
| North America | $203,003 | $206,858 | $(3,855) | -2 |
| Europe | 72,754 | 68,366 | 4,388 | +6 |
| Latin America | 42,587 | 42,445 | 142 | — |
| Asia | 15,417 | 13,418 | 1,999 | +15 |
| Total Surfactants Segment | $333,761 | $331,087 | $2,674 | +1 |
30
Net sales for North American operations declined two percent due to an eleven percent decrease in sales volume and the effects of foreign currency translation, which negatively affected the quarter-over-quarter change in net sales by $22.7 million and $0.9 million, respectively. Decreased sales of products used in laundry and cleaning, personal care, agricultural chemical and biodiesel applications accounted for the North American sales volume decline. These decreases in sales volumes were partially offset by sales volume growth for products used in oil field and household, industrial and institutional applications. The declines in laundry and cleaning and personal care sales volumes were primarily attributable to customers bringing surfactant production in-house to more fully utilize their internal capacity. The lower agricultural chemical sales volume reflected lower customer demand resulting from a spring planting season that was shortened due to prolonged winter weather in parts of the U.S. The Company chose not to sell and manufacture biodiesel products in the second quarter of 2014 because to do so would not have been economically advantageous. Average selling prices increased eleven percent, which offset the effects of the sales volume decline and unfavorable foreign currency translation by $19.7 million. Higher quarter-over-quarter raw material costs led to the increase in average selling prices.
Net sales for European operations increased six percent due to the effects of foreign currency translation and a two percent increase in average selling prices, which accounted for $4.5 million and $1.6 million, respectively, of the quarter-over-quarter net sales growth. A stronger European euro and British pound sterling versus the U.S. dollar led to the favorable translation impact. A more favorable mix of sales along with some recouping of raw material cost increases led to the higher average selling prices. Sales volume declined two percent between quarters, which negatively affected the quarter-over-quarter net sales change by $1.7 million. The decline in sales volume reflected lower demand for laundry and cleaning and personal care products. Higher agricultural chemical sales volume and increased sales of general surfactants sold through distributors partially offset the volume declines for laundry and cleaning and personal care products.
Net sales for Latin American operations increased less than one percent between quarters. The effect of a 12 percent increase in average selling prices, which favorably affected the quarter-over-quarter net sales change by $4.9 million, was mostly offset by a six percent decline in sales volume and the effects of foreign currency translation, which negatively affected the quarter-over-quarter net sales change by $2.6 million and $2.2 million, respectively. The selling price increase was largely due to the recovery of higher raw material costs. The sales volume decline reflected a temporary plant shutdown at a large customer and decreased agricultural chemical sales due to drought conditions in Brazil. The foreign currency translation effect resulted from the quarter-over-quarter weakening of the Brazilian real and Colombian and Mexican pesos against the U.S. dollar.
Net sales for Asian operations increased 15 percent due to a four percent increase in sales volume and increased average selling prices partially offset by $0.8 million of unfavorable foreign currency translation effect.
Surfactants operating income for the second quarter of 2014 declined $6.7 million, or 26 percent, from operating income for the second quarter of 2013. Gross profit decreased $7.5 million principally due to lower sales volume and higher expenses in North America. The effect of higher average raw material costs was largely offset by selling price increases. Operating expenses declined $0.8 million, or three percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:
(In thousands)
| Gross Profit | For the Three Months Ended June 30, 2014 | June 30, 2013 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $23,357 | $33,461 | $(10,104) | -30 |
| Europe | 7,024 | 6,563 | 461 | +7 |
| Latin America | 4,739 | 6,398 | (1,659) | -26 |
| Asia | 5,726 | 1,908 | 3,818 | +200 |
| Surfactants Segment Gross Profit | $40,846 | $48,330 | $(7,484) | -15 |
| Operating Expenses | 21,607 | 22,364 | (757) | -3 |
| Operating Income | $19,239 | $25,966 | $(6,727) | -26 |
North American gross profit declined 30 percent quarter over quarter due to lower sales volume and higher expenses. Manufacturing costs were up $2.1 million quarter over quarter largely due to carryover maintenance projects from the severe winter weather in the first quarter of 2014. The Company also incurred additional transportation expenses due to sulfonation production issues at its Anaheim, California, plant, which resulted in shifting production to other locations. The Company’s Canadian plant recognized $0.9 million of accelerated depreciation related to the restructuring plan approved in the fourth quarter of 2013. No further accelerated depreciation is expected to be recognized in connection with the restructuring. It is expected that the savings from this restructuring initiative will begin in the second half of 2014, with a full annual run rate of approximately $2.5 million.
Gross profit for European operations increased seven percent quarter over quarter. A more favorable mix of sales and a $0.4 million favorable foreign currency translation effect more than offset the impact of a two percent decline in sales volume.
Gross profit for Latin American operations declined 26 percent due to a less favorable mix of sales, a six percent decline in sales volume and an unfavorable $0.3 million foreign currency translation impact. The change in sales mix and lower sales volume were largely due to the decline in agricultural chemical sales resulting from drought conditions in Brazil.
The quarter-over-quarter increase in gross profit for Asian operations was primarily driven by increased methyl esters sales volume shipped from the region’s Singapore location to the U.S.
Operating expenses for the Surfactants segment declined $0.8 million, or three percent, quarter over quarter. Lower selling and R&D expenses for North American operations ($0.5 million and $0.4 million, respectively) accounted for the decline. With respect to selling expenses, 2013 results included consulting fees that did not recur in 2014. Lower fringe benefits, largely due to reduced incentive pay expenses, also contributed. The decline in R&D expenses was attributable to lower expenses for outside services and fringe benefits.
Polymers
Polymers net sales for the second quarter of 2014 increased $26.9 million, or 22 percent, over net sales for the same quarter of 2013. A 22 percent increase in sales volume and the effects of foreign currency translation accounted for $27.3 million and $2.4 million, respectively, of the quarter-over-quarter net sales improvement. North American and European operations posted strong growth between quarters. Average selling prices declined, which negatively impacted the net sales change by $2.8 million. A quarter-over-quarter comparison of net sales by region follows:
(In thousands)
| For the Three Months Ended June 30, 2014 | June 30, 2013 | Increase | Percent Change | |
|---|---|---|---|---|
| North America | $94,022 | $74,534 | $19,488 | +26 |
| Europe | 46,105 | 39,542 | 6,563 | +17 |
| Asia and Other | 8,143 | 7,249 | 894 | +12 |
| Total Polymers Segment | $148,270 | $121,325 | $26,945 | +22 |
Net sales for North American operations increased 26 percent due to a 29 percent increase in sales volume. Specialty polyols, which includes the polyester resin business acquired from BMS in June 2013, accounted for about half of the sales volume increase. Sales volume for polyols used in rigid foam applications improved 19 percent, mostly due to an improving economy and to the positive effects of recommendations to use more insulation to conserve energy. Also, the protracted inclement winter weather in the first quarter of the year resulted in additional second quarter demand due to a late start to the construction season (pushing first quarter business to the second quarter) and to an increase in the quantity of weather-related roofing repairs and replacements. Sales volume of phthalic anhydride declined eight percent due to lost sales at a large customer.
Net sales for European operations increased 17 percent due to a 16 percent increase in sales volume. Demand for the Company’s polyol products used in rigid insulation board and metal panels remained strong due to local regulations aimed at increasing energy conservation and to heightened interest in energy-efficient insulation materials. A $2.6 million favorable foreign currency translation effect was offset by a decline in average selling prices.
Net sales for Asia and Other regions increased 12 percent quarter over quarter due to higher average selling prices resulting from a more favorable mix of sales.
Currently the Company supplies its customers in China and other parts of Asia with product imported from other Company sites and from local manufacturers. This sourcing is expected to continue until a new plant in China is operational, which is currently projected to be in the first half of 2016.
Polymers operating income for the second quarter of 2014 increased $4.9 million, or 36 percent, over operating income for last year’s second quarter. Gross profit increased $5.2 million quarter-over-quarter, due to the 22 percent increase in sales volume. All segment regions contributed to the profit improvement. Operating expenses increased $0.3 million, or five percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:
(In thousands)
| Gross Profit | For the Three Months Ended June 30, 2014 | June 30, 2013 | Increase | Percent Change |
|---|---|---|---|---|
| North America | $17,773 | $14,970 | $2,803 | +19 |
| Europe | 6,794 | 5,259 | 1,535 | +29 |
| Asia and Other | 589 | (289) | 878 | NM |
| Polymers Segment Gross Profit | $25,156 | $19,940 | $5,216 | +26 |
| Operating Expenses | 6,712 | 6,416 | 296 | +5 |
| Operating Income | $18,444 | $13,524 | $4,920 | +36 |
Gross profit for North American operations increased 19 percent due to the 29 percent increase in sales volume. The polyester resins business acquired from BMS in June 2013 accounted for over half of the quarter-over-quarter gross profit improvement due to three months of activity being included in 2014 second quarter financial results compared to one month in the second quarter of 2013.
Gross profit for European operations increased 29 percent primarily due to the 16 percent increase in sales volume. A $0.4 million favorable foreign currency translation effect also contributed to the gross profit increase.
The increase in gross profit for Asia and Other regions was largely due to $0.5 million of accelerated depreciation charged in the second quarter of 2013 that did not recur in 2014. The accelerated depreciation reflected the winding down of manufacturing operations at the Company’s Nanjing, China, plant. A more favorable mix of sales also contributed to the gross profit improvement.
Operating expenses for the Polymers segment were up $0.3 million, or five percent, quarter over quarter. The increase reflected higher marketing expenses and the effects of foreign currency translation.
Specialty Products
Net sales for the second quarter of 2014 approximated net sales for the second quarter of 2013. Sales volume was also unchanged between quarters as increased sales volume for food ingredient products was offset by decreased sales volumes for products used in nutritional supplement, flavoring and pharmaceutical applications. Operating income declined $0.6 million, or 15 percent, quarter over quarter due to the timing of pharmaceutical orders and to higher operating expenses.
Corporate Expenses
Corporate expenses, which comprise operating expenses that are not allocated to the reportable segments, declined $3.5 million to $4.3 million for the second quarter of 2014 from $7.8 million for the same quarter of 2013. The quarter-over-quarter decline in corporate expenses was primarily attributable to an increase in deferred compensation income ($1.9 million) and decreases in patent ($0.5 million), fringe benefit ($0.5 million) and insurance ($0.3 million) expenses. The increase in deferred compensation income ($5.5 million of income for the second quarter of 2014 compared to $3.6 million of income for the second quarter of 2013) reflected an
$11.70 per share 2014 second quarter decline in the value of Company stock, to which a substantial portion of the deferred compensation obligation is tied, compared to a second quarter 2013 decline of $7.49 per share. The following table presents the quarter end Company common stock market prices used in the computation of deferred compensation expense:
| 2014 June 30 | March 31 | 2013 June 30 | March 31 | |
|---|---|---|---|---|
| Company Stock Price | $52.86 | $64.56 | $55.61 | $63.10 |
Six Months Ended June 30, 2014 and 2013
Summary
Net income attributable to the Company for the first half of 2014 declined 11 percent year-over-year to $37.4 million, or $1.63 per diluted share, compared to $41.8 million, or $1.82 per diluted share, for the first half of 2013. The current year’s financial results were negatively impacted by weaker first quarter 2014 earnings largely due to the effects of protracted severe winter weather in the U.S. Below is a summary discussion of the major factors leading to the year-over-year changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first half of 2014 follows the summary.
Consolidated net sales increased $50.6 million, or five percent, between years. Higher average selling prices and the effects of foreign currency translation favorably affected the net sales change by $68.9 million and $1.5 million, respectively. A two percent decline in sales volume negatively affected the net sales change by $19.8 million. The increase in average selling prices was attributable to higher year-over-year raw material costs for Surfactants. The Surfactants segment accounted for the consolidated sales volume decrease. Surfactants sales volume declined seven percent largely due to reduced volumes for North American operations. Sales volume for the Polymers segment increased 22 percent due to strong growth in North America and Europe as well to the contribution of the North American polyester resins business acquired from BMS in June 2013. Sales volume for Specialty Products declined four percent.
Operating income for the first half of 2014 declined $4.7 million, or seven percent, from operating income reported for the first half of 2013. Gross profit decreased $11.8 million, or eight percent, largely due to lower profits for Surfactants mainly driven by lower sales volume and higher expenses for operations in North America. The drop in gross profit for Surfactants was partially offset by a 16 percent increase in gross profit for Polymers.
Operating expenses declined $7.1 million, or nine percent, year over year. Deferred compensation expense accounted for $7.0 million of the decrease. The following summarizes the year-over-year changes in the individual income statement line items that comprise the Company’s operating expenses:
- Administrative expenses declined $7.4 million, or 24 percent, year over year due to a $7.0 million reduction in deferred compensation expense. A first half 2014 decrease in the value of Company stock compared to a first half 2013 increase in the value of Company common stock led to the year-over-year decline in deferred compensation expense. See the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details.
- Selling expenses declined $0.5 million, or two percent, year over year.
- Research, development and technical service expenses (R&D) were up $0.8 million, or four percent, year over year. About half of the increase was attributable to the write-off of design and engineering costs for a lab upgrade capital project that the Company decided not to pursue.
Net interest expense for the first half of 2014 increased $1.5 million, or 33 percent, over net interest expense for the first half of 2013. The increase reflected higher average debt levels arising from the $100.0 million private placement note purchase agreement the Company executed in June 2013. The Company borrowed the funds to finance the second quarter 2013 BMS North American polyester resins acquisition, other capital expenditures and general corporate purposes.
Other, net for the first half of 2014 was $0.5 million income, which was essentially the same as last year’s first half. Foreign exchange losses were down $0.3 million between years, and investment income for the Company’s deferred compensation and supplemental defined contribution mutual fund assets (including realized and unrealized gains and losses) was down by $0.3 million.
The effective tax rate was 27.1 percent for the first half of 2014 compared to 27.5 percent for the first half of 2013. The decrease was primarily attributable to a greater percentage of consolidated income being generated outside the U.S. where the effective tax rates are generally lower. This decrease was mostly offset by the expiration of the U.S. research and development tax credit and the small agri-biodiesel producer tax credit.
Segment Results
(In thousands)
| For the six months ended June 30, 2014 | Surfactants | Polymers | Specialty Products | Segment Results | Corporate | Total |
|---|---|---|---|---|---|---|
| Net sales | $669,471 | $267,377 | $44,705 | $981,553 | — | $981,553 |
| Operating income | 37,577 | 29,270 | 7,571 | 74,418 | (14,981) | 59,437 |
| For the six months ended June 30, 2013 | ||||||
| Net sales | $671,060 | $217,323 | $42,608 | $930,991 | — | $930,991 |
| Operating income | 55,618 | 24,288 | 7,029 | 86,935 | (22,772) | 64,163 |
Surfactants
Surfactants net sales for the first half of 2014 declined $1.6 million, or less than one percent, from net sales for the first half of 2013. A seven percent drop in sales volume mainly attributable to North American operations and the effects of foreign currency translation accounted for $47.4 million and $2.4 million, respectively, of the net sales decline. An increase in average selling prices favorably affected the net sales change by $48.2 million. A year-over-year comparison of net sales by region follows:
(In thousands)
| For the Six Months Ended June 30, 2014 | June 30, 2013 | Increase (Decrease) | Percent Change | |
|---|---|---|---|---|
| North America | $411,427 | $418,320 | $(6,893) | -2 |
| Europe | 148,112 | 146,549 | 1,563 | +1 |
| Latin America | 81,294 | 80,647 | 647 | +1 |
| Asia | 28,638 | 25,544 | 3,094 | +12 |
| Total Surfactants Segment | $669,471 | $671,060 | $(1,589) | — |
Net sales for North American operations declined two percent due to an 11 percent decrease in sales volume and the unfavorable effects of foreign currency translation, which accounted for $47.2 million and $2.2 million, respectively, of the decline in net sales. Decreased sales of products used in biodiesel, laundry and cleaning, personal care and agricultural chemical applications accounted for the North American sales volume decline. These sales volume decreases were partially offset by sales volume growth for products used in oil field and household, industrial and institutional applications and for surfactants sold through distributors. The Company chose not to manufacture and sell biodiesel products in the first half of 2014 because to do so would not have been economically advantageous. The decline in laundry and cleaning and personal care sales volume was largely attributable to the severe winter weather that caused production issues at some Company and customer manufacturing facilities and to customers bringing surfactant production in-house to more fully utilize their internal capacity. The decline in agricultural chemical sales volume reflected lower customer demand resulting from a spring planting season that was shortened due to prolonged winter weather in parts of the U.S. Average selling prices increased 11 percent, which offset the effects of the sales volume decline and unfavorable foreign currency translation by $42.5 million. Higher year-over-year raw material costs led to the higher average selling prices.
Net sales for European operations increased one percent due to an $8.3 million favorable effect of foreign currency translation. Both the European euro and British pound sterling strengthened against the U.S. dollar year over year. Sales volume declined four percent, which offset the impact of currency translation by $6.2 million. A less than one percent decrease in average selling prices had a $0.5 million negative effect on the year-over-year change in net sales. The decline in sales volume reflected lower demand for laundry and cleaning and personal care products as well as some lost business resulting from competitive pricing situations. Sales volumes for functional surfactants, primarily agricultural and emulsion polymers and foamers products, were up year over year.
Net sales for Latin American operations increased one percent due to a seven percent increase in average selling prices and a one percent increase in sales volume, which accounted for $6.0 million and $1.0 million, respectively, of the year-over-year net sales change. Higher raw material costs led to the increase in average selling prices. The year-over-year sales volume change was tempered by lower second quarter-over-quarter sales volume resulting from a temporary plant shutdown at a large customer and decreased agricultural chemical sales due to drought conditions in Brazil. The effects of foreign currency translation negatively affected the change in net sales by $6.4 million. The foreign currency translation effect resulted from the quarter-over-quarter weakening of the Brazilian real and the Colombian and Mexican pesos against the U.S. dollar.
Net sales for Asian operations increased 12 percent due to a six percent increase in sales volume and increased average selling prices partially offset by $2.0 million of unfavorable foreign currency translation effect.
Surfactants operating income for the first half of 2014 declined $18.0 million, or 32 percent, from operating income for the first half of 2013. Gross profit decreased $18.3 million principally due to lower sales volume and higher expenses in North America. Foreign currency translation contributed $0.7 million to the gross profit decline. Operating expenses declined $0.3 million, or one percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:
(In thousands)
| Gross Profit | For the Six Months Ended June 30, 2014 | June 30, 2013 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $48,330 | $72,935 | $(24,605) | -34 |
| Europe | 14,360 | 13,432 | 928 | +7 |
| Latin America | 10,042 | 11,890 | (1,848) | -16 |
| Asia | 8,922 | 1,721 | 7,201 | +418 |
| Surfactants Segment Gross Profit | $81,654 | $99,978 | $(18,324) | -18 |
| Operating Expenses | 44,077 | 44,360 | (283) | -1 |
| Operating Income | $37,577 | $55,618 | $(18,041) | -32 |
North American gross profit declined 34 percent due to reduced sales volume and higher expenses. Manufacturing costs were up $6.2 million year over year largely due to increased maintenance and utility costs caused by prolonged inclement winter weather. The Company also incurred additional transportation expenses due to the transfer of some production in weather-affected locations to other less impacted North American plants and to sulfonation production issues at its Anaheim, California, plant, which also resulted in shifting production to other locations. In addition to the foregoing, the Company recognized $1.8 million of accelerated depreciation in the first half of the current year related to the North American restructuring plan approved in the fourth quarter of 2013. No further accelerated depreciation is expected to be recognized in connection with the restructuring.
Gross profit for European operations increased seven percent year over year. A more favorable mix of sales, lower material costs and a $0.7 million favorable foreign currency translation effect more than offset the impact of a four percent decline in sales volume.
Gross profit for Latin American operations declined 16 percent due to a less favorable mix of sales, higher raw material costs and an unfavorable $1.0 million foreign currency translation impact that more than offset the effect of a one percent increase in sales volume.
The quarter-over-quarter increase in gross profit for Asian operations was driven by increased sales volume, including increased shipments of methyl esters from Singapore to the U.S.
Operating expenses for the Surfactants segment were down $0.3 million, or one percent, between years. The expense decrease was attributable to lower selling expenses and to the effects of foreign currency translation.
Polymers
Polymers net sales for the first half of 2014 increased $50.1 million, or 23 percent, over net sales for the same period of 2013. A 22 percent increase in sales volume and the effects of foreign currency translation accounted for $46.9 million and $3.5 million, respectively, of the year-over-year net sales improvement. The increase in sales volume was attributable to solid growth for North American and European operations. A decline in average selling prices had a $0.3 million negative impact on the net sales change. A year-over-year comparison of net sales by region follows:
(In thousands)
| For the Six Months Ended June 30, 2014 | June 30, 2013 | Increase | Percent Change | |
|---|---|---|---|---|
| North America | $167,707 | $134,593 | $33,114 | +25 |
| Europe | 87,781 | 72,592 | 15,189 | +21 |
| Asia and Other | 11,889 | 10,138 | 1,751 | +17 |
| Total Polymers Segment | $267,377 | $217,323 | $50,054 | +23 |
Net sales for North American operations increased 25 percent due to a 23 percent increase in sales volume. Specialty polyols, which includes the polyester resin business acquired from BMS in June 2013, accounted for about 68 percent of the sales volume increase. Sales volume for polyols used in rigid foam applications improved 13 percent, principally due to an improved construction economy and to the positive effects of recommendations to use more insulation to conserve energy. Sales volume of phthalic anhydride declined nine percent due to lost sales at a large customer.
Net sales for European operations increased 21 percent due to a 22 percent increase in sales volume and to the effects of foreign currency translation, which accounted for $16.0 million and $3.7 million, respectively, of the net sales improvement. Strong demand continued for the Company’s polyol products used in rigid insulation board and metal panels. Average selling prices declined five percent, which reduced the year-over-year net sales improvement by $4.5 million.
Net sales for Asia and Other regions increased 17 percent between years due to a three percent increase in sales volume, higher average selling prices and a more favorable sales mix.
Polymers operating income for the first half of 2014 increased $5.0 million, or 21 percent, over operating income for the first half of 2013. Gross profit increased $5.9 million year over year due to a 22 percent increase in sales volume. Operating expenses increased $0.9 million, or eight percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:
(In thousands)
| Gross Profit | For the Six Months Ended June 30, 2014 | June 30, 2013 | Increase | Percent Change |
|---|---|---|---|---|
| North America | $29,207 | $26,381 | $2,826 | +11 |
| Europe | 12,315 | 10,396 | 1,919 | +18 |
| Asia and Other | 899 | (286) | 1,185 | NM |
| Polymers Segment Gross Profit | $42,421 | $36,491 | $5,930 | +16 |
| Operating Expenses | 13,151 | 12,203 | 948 | +8 |
| Operating Income | $29,270 | $24,288 | $4,982 | +21 |
39
Gross profit for North American operations increased 11 percent due to the 23 percent increase in sales volume. Specialty polyols, which includes the polyester resin business acquired from BMS in June 2013, accounted for most of the year-over-year gross profit improvement due to six months of the new polyester resin activity being included in the 2014 financial results compared to one month in the 2013 results. The year-over-year gross profit change was tempered by reduced contribution from phthalic anhydride sales, particularly for the first quarter of 2014 when higher costs negatively impacted the product’s sales margin.
Gross profit for European operations increased eighteen percent due to the 22 percent increase in sales volume and a $0.6 million favorable effect of foreign currency translation. Selling price reductions and higher manufacturing expenses partially offset the effect of the improved sales volume.
The increase in gross profit for Asia and Other regions was largely due to $0.6 million of accelerated depreciation charged in the first half of 2013 that did not recur in 2014, a more favorable mix of sales and increased sales volume. The accelerated depreciation reflected the winding down of manufacturing operations at the Company’s Nanjing, China, plant.
Operating expenses for the Polymers segment were up $0.9 million, or eight percent, between years. Increased selling expense for North American and European operations ($0.2 million each), increased R&D expense for North American operations ($0.2 million) and the effects of foreign currency translation ($0.2 million) accounted for most of the higher year-over-year operating expenses.
Specialty Products
Net sales for the first half of 2014 increased $2.1 million, or five percent, over net sales for the same period of 2013. Sales volume declined four percent primarily due to reduced sales of products used in flavoring applications. Selling price increases for food ingredient and nutritional supplement products more than offset the effect of the sales volume decline. Operating income increased $0.5 million, or eight percent, principally due to higher selling prices.
Corporate Expenses
Corporate expenses declined $7.8 million to $15.0 million for the first half of 2014 from $22.8 million for the same period of 2013. The decline in corporate expenses was principally the result of a $7.0 million decrease in deferred compensation expense ($5.7 million of income for the first half of 2014 compared to $1.3 million of expense for the first half of 2013). A first half 2014 decrease ($12.77 per share) in the value of Company stock compared to a first half 2013 increase ($0.07 per share) in the value of Company common stock led to the year-over-year decline in deferred compensation expense. The following table presents the quarter end Company common stock market prices used in the computation of deferred compensation expense:
| 2014 June 30 | 2013 December 31 | June 30 | 2012 December 31 | |
|---|---|---|---|---|
| Company Stock Price | $52.86 | $65.63 | $55.61 | $55.54 |
Decreases in fringe benefit and insurance expenses contributed to the year-over-year decline in corporate expenses.
LIQUIDITY AND CAPITAL RESOURCES
For the six months ended June 30, 2014, operating activities were a cash source of $15.0 million versus a source of $41.8 million for the comparable period in 2013. For the current year period, investing cash outflows totaled $42.4 million and financing activities consumed $9.9 million. Cash decreased by $36.9 million with exchange rates increasing cash by $0.4 million.
For the current year-to-date, net income was down by $4.3 million and working capital consumed $22.4 million more than for the comparable year-ago period. Cash outflows for investing activities were down by $65.9 million year over year. Cash flow for financing activities was a use of $9.9 million in 2014 compared to a source of $99.3 million in 2013.
For the current year-to-date, accounts receivable were a use of $39.1 million compared to a use of $49.2 million for the comparable period in 2013. Inventories were a use of $30.6 million in 2014 versus a use of $4.0 million in 2013. Accounts payable and accrued liabilities were a source of $16.5 million in 2014 compared to a source of $29.5 million for the same period in 2013.
Working capital requirements were higher during the first half of 2014, compared to the same period in 2013 due mainly to a larger increase in inventory quantities year over year combined with rising raw material costs in 2014 versus falling raw material costs in 2013. The Company’s working capital investment is heavily influenced by the cost of crude oil and natural oils, from which many of its raw materials are derived. Fluctuations in raw material costs translate directly to inventory carrying costs and indirectly to customer selling prices and accounts receivable.
The year-to-date accounts receivable increase was driven mainly by higher selling prices, partially offset by improved accounts receivable turnover since year-end. The year-to-date inventory cash use was driven mainly by higher quantities to support customer service levels for the U.S. The Company has not changed its own payment practices related to its payables. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during 2014.
Investing cash outflows for the current year-to-date included capital expenditures of $39.1 million compared to $42.0 million for the comparable period last year. Other investing activities consumed $3.4 million in 2014 versus $3.7 million in 2013.
For 2014, the Company estimates that capital expenditures will range from $100 million to $110 million including capacity expansions in Brazil, Germany, Singapore and the United States.
The Company purchases its common shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit. For the six months of 2014, the Company purchased 89,868 shares in the open market at a total cost of $4.9 million. At June 30, 2014, there were 868,444 shares remaining under the current share repurchase authorization.
As of June 30, 2014, the Company’s cash and cash equivalents totaled $96.4 million, including $21.9 million in two separate U.S. money market funds, each of which was rated AAA by Standard and Poor’s and Aaa by Moody’s. Cash in U.S. demand deposit accounts totaled $20.3 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaled $54.2 million at June 30, 2014.
Consolidated balance sheet debt increased by $0.7 million for the current year-to-date, from $270.6 million to $271.3 million. Since last year-end, foreign debt increased by $0.7 million and domestic debt was unchanged. Net debt (which is defined as total debt minus cash) increased by $37.6 million for the current year-to-date, from $137.3 million to $174.9 million. As of June 30, 2014, the ratio of total debt to total debt plus shareholders’ equity was 31.6 percent compared to 32.8 percent at December 31, 2013. As of June 30, 2014, the ratio of net debt to net debt plus shareholders’ equity was 23.0 percent compared to 19.9 percent at December 31, 2013.
At June 30, 2014, the Company’s debt included $242.1 million of unsecured private placement loans with maturities extending from 2014 through 2025. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.
On July 10, 2014, the Company amended the committed $125.0 million multi-currency five-year revolving credit agreement with JPMorgan Chase Bank, N.A., as administrative agent, and four U.S. banks named as lenders thereunder. The credit agreement allows the Company to make unsecured borrowings, as requested from time to time, for working capital and other corporate purposes. The amendment extends the maturity date of the 2012 Agreement from September 20, 2017 to July 10, 2019. This unsecured facility is the Company’s primary source of short-term borrowings with terms and conditions that are substantially equivalent to those of the Company’s other U.S. loan agreements. As of June 30, 2014, the Company had outstanding letters of credit of $3.0 million under the credit agreement and no borrowings, with $122.0 million remaining available. The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.
Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At June 30, 2014, the Company’s European subsidiaries had bank term loans of $4.5 million with maturities through 2016 and short-term bank debt of $24.0 million with remaining short-term borrowing capacity of $12.0 million. The Company’s Latin American subsidiaries had no short-term bank debt with $16.8 million of unused short-term borrowing capacity. The Company’s Philippine subsidiary had $0.7 million of short-term bank loans, which were guaranteed by the Company, with $7.3 million of unused borrowing capacity. The Company’s majority-owned joint venture in China had no short-term bank debt, with unused borrowing capacity of $6.5 million, on bank credit lines guaranteed by the Company.
The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of the Company, Stepan Canada Inc., Stepan Quimica Ltda., Stepan Specialty Products, LLC, Stepan Specialty Products B.V. and Stepan Asia Pte. Ltd. (the “Restricted Group”). Under the most restrictive of these debt covenants:
1. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 2.0 to 1.0, for the preceding four calendar quarters.
2. The Restricted Group must maintain net worth of at least $275.0 million.
3. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 55 percent.
4. The Restricted Group may pay dividends and purchase treasury shares after December 31, 2011, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively after June 30, 2012. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 12, Debt, in the Notes to Consolidated Financial Statements.
The Company believes it was in compliance with all of its loan agreements as of June 30, 2014. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2014.
ENVIRONMENTAL AND LEGAL MATTERS
The Company is subject to extensive federal, state and local environmental laws and regulations. Although the Company’s environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first six months of 2014 and 2013, the Company’s expenditures for capital projects related to the environment were $1.8 million and $2.6 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $9.6 million and $8.6 million for the six months ended June 30, 2014 and 2013, respectively. While difficult to project, it is not anticipated that these recurring expenses will increase significantly in the future.
Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $10.1 million to $29.1 million at June 30, 2014, compared to $9.7 million to $28.9 million at December 31, 2013. At June 30, 2014, and December 31, 2013, the Company’s accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $15.1 million and $14.7 million, respectively. During the first six months of 2014, cash outlays related to legal and environmental matters approximated $0.5 million compared to $1.3 million for the first six months of 2013.
For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Given the information available, management believes the Company has no liability at these sites. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.
ACQUISITION AGREEMENT
On July 15, 2014, the Company announced that it reached an agreement with Procter & Gamble do Brasil S.A. to acquire (through the Company’s Brazilian subsidiary) a sulfonation production facility in Bahia, Brazil, subject to approval by the Brazilian antitrust authorities and by the Industrial Development Superintendent of the State of Bahia, as well as other customary closing conditions. The facility is located in northeastern Brazil and has 30,000 metric tons of capacity. The acquisition is expected to expand the Company’s capabilities in Brazil, which is the world’s fifth most populous country and has a growing middle class. As the country’s usage of laundry products transitions from soap bars to powders to liquids, surfactant use expands. Surfactants used in functional applications, including the large Brazilian agricultural industry, are also increasing. Brazil is a strategic priority for Stepan. This acquisition is synergistic with the Company’s existing Vespasiano, Brazil, plant and provides an opportunity to serve growing northeastern Brazil. The transaction is projected to close in the third or fourth quarter of 2014. The acquisition is expected to have a minimal impact on the Company’s 2014 financial results. Financial terms of the transaction were not disclosed.
OUTLOOK
The second quarter had its share of challenges, but by delivering on its strategic initiatives the Company matched prior year earnings. As previously communicated, the lower first quarter earnings will make it difficult to exceed 2013 full year earnings from operations.
The challenges to our Surfactant business in North America are expected to continue for the remainder of the year. Consumer product volumes are expected to be down due to greater use of internal capacity by customers. The North America agricultural market had a slow start and is expected to have a down year. The Brazil agricultural market is expected to improve in the second half. Contributions from EOR and efficiency projects should improve in the second half.
Polymers should continue to deliver strong volume growth globally. Improving economies in the U.S. and Europe as well as greater use of insulation, should contribute to full year Polymer growth. The North American polyester resin business purchased from BMS is fully integrated and is expected to deliver income as projected.
CRITICAL ACCOUNTING POLICIES
There have been no changes to the critical accounting policies disclosed in the Company’s 2013 Annual Report on Form 10-K.
Controls and procedures
As filed, 728 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
a. Evaluation of Disclosure Controls and Procedures
Based on their evaluation of our disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this Form 10-Q, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) were effective as of June 30, 2014.
b. Changes in Internal Control Over Financial Reporting
There were no changes in internal controls that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-04-01 to 2014-06-30 | $504.1m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2014-01-01 to 2014-06-30 | $981.6m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-04-01 to 2014-06-30 | $432.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2014-01-01 to 2014-06-30 | $846.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2014-04-01 to 2014-06-30 | $71.6m | us-gaap:GrossProfit |
| Gross profit | 6 months2014-01-01 to 2014-06-30 | $134.6m | us-gaap:GrossProfit |
| Operating income | 3 months2014-04-01 to 2014-06-30 | $36.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2014-01-01 to 2014-06-30 | $59.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-04-01 to 2014-06-30 | $3.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2014-01-01 to 2014-06-30 | $6.0m | us-gaap:InterestExpense |
| Income tax | 3 months2014-04-01 to 2014-06-30 | $8.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2014-01-01 to 2014-06-30 | $13.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-04-01 to 2014-06-30 | $24.4m | us-gaap:NetIncomeLoss |
| Net income | 6 months2014-01-01 to 2014-06-30 | $37.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-04-01 to 2014-06-30 | $1.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2014-01-01 to 2014-06-30 | $1.63 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-04-01 to 2014-06-30 | $1.07 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2014-01-01 to 2014-06-30 | $1.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-04-01 to 2014-06-30 | 22,931,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2014-01-01 to 2014-06-30 | 22,948,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2014-01-01 to 2014-06-30 | $15.0m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months2014-01-01 to 2014-06-30 | $39.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2014-01-01 to 2014-06-30 | $7.6m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2014-01-01 to 2014-06-30 | $4.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-06-30 | $96.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-06-30 | $641.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-06-30 | $1.21bn | us-gaap:Assets |
| Current liabilities | At period end2014-06-30 | $284.0m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2014-06-30 | $233.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2014-06-30 | $37.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2014-06-30 | $585.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-14-285984. Last ingested by Listed: Nov 10, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.